Bio-Techne
TECH
257 hedge funds and large institutions have $3.53B invested in Bio-Techne in 2016 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 108 increasing their positions, 88 reducing their positions, and 28 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
23% more repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 88
5% more capital invested
Capital invested by funds: $3.36B → $3.53B (+$173M)
1% less funds holding
Funds holding: 260 → 257 (-3)
11% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 28
Top Buyers
| 1 |
Select Equity Group
New York
|
+$68.1M |
| 2 |
Goldman Sachs
New York
|
+$17M |
| 3 |
BAMCO Inc
New York
|
+$14.2M |
| 4 |
Millennium Management
New York
|
+$9.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.74M |
Top Sellers
TECH Hedge Fund Activity: Q1 2016 in Review
257 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2016, worth a combined $3.53B — up 5.2% from $3.36B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of TECH and 25 opened new positions — a net loss of 3 holders — while 88 trimmed existing stakes and 108 added.
The largest buyer was Select Equity Group, adding an estimated $68.1M. The largest seller was First Trust Advisors, cutting an estimated $93.6M.
- 257 institutional investors held Bio-Techne (TECH) as of Q1 2016, down from 260 in Q4 2015.
- Funds reported $3.53B of Bio-Techne stock for Q1 2016, up 5.2% quarter-over-quarter.
- 25 funds opened new Bio-Techne positions in Q1 2016 and 28 closed out, a net change of -3 holders.
- The largest Bio-Techne buyer in Q1 2016 was Select Equity Group, an estimated $68.1M added.
- The largest Bio-Techne seller in Q1 2016 was First Trust Advisors, an estimated $93.6M sold.
Based on aggregated 13F filings for Q1 2016.